AstraZeneca Covid-19 vaccine shows promise in elderly
Published
The data suggest that those aged over 70, who are at higher risk of serious illness and death from Covid-19, could build robust immunity.
Full ArticlePublished
The data suggest that those aged over 70, who are at higher risk of serious illness and death from Covid-19, could build robust immunity.
Full ArticleWatch VideoThe Oxford-Astrazeneca vaccine trial has some good news after early data found its candidate is working well in older..
AstraZeneca and Oxford University's potential COVID-19 vaccine produced a strong immune response in older adults, data published on..